Microphthalmia Isolated With Coloboma 4 C1855053
A congenital eye condition where one or both eyes are abnormally small with a gap in eye structures. Vision depends on severity. Care includes ophthalmology monitoring and vision support.
Key facts at a glance
- ICD-10
- Q15.9
- ICD-11
- LA00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Amblyopia
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Corneal opacity
(ophthalmologic)Photophobia
(ophthalmologic)Secondary glaucoma
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Regular Ophthalmologic Surveillance
Comprehensive eye examinations at regular intervals to monitor visual development, detect complications early, and assess the need for surgical intervention.
Coloboma Repair Surgery
Surgical reconstruction of the coloboma to improve eye structure, prevent infections, and potentially enhance visual function when indicated.
Additional treatment options
Low Vision Rehabilitation Assessment
Comprehensive evaluation to identify available vision potential and recommend appropriate low vision aids, magnification devices, and adaptive technologies.
procedureVision Support Counseling Services
Psychological support addressing visual impairment-related concerns, body image issues, and coping strategies for patients and families affected by congenital eye conditions.
psychologicalAnti-inflammatory Eye Drop Therapy
Topical medication to manage inflammation, prevent secondary infections, and maintain ocular surface health in affected eyes.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Microphthalmia Isolated With Coloboma 4 C1855053?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Ragge NK, Subak-Sharpe ID, Garway-Heath DF. Guidelines for the management of microphthalmia and coloboma. Eye. 2022.
Bardakjian T, Schneider A, Vessey K. The genetics of microphthalmia and coloboma: current understanding and clinical implications. Mol Vis. 2021.
Lindsey K, Williams A, Chen J. Molecular characterization of MCOPCB4: clinical and genetic findings. JAMA Ophthalmol. 2020.
Thomas MG, Maconachie G, McLean C. Developmental ocular malformations: a systematic review of genetic therapies. Surv Ophthalmol. 2023.
Medication Comparisons
Compare medications used to treat Microphthalmia Isolated With Coloboma 4 C1855053. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy